Death toll in DR Congo from Ebola outbreak now at 61

Image
AFP Beni
Last Updated : Aug 23 2018 | 6:10 PM IST

Sixty-one people have died in the latest outbreak of Ebola in the Democratic Republic of Congo (DRC), the authorities said, adding that four novel drugs had been added to the roster of treatments.

The health ministry's General Directorate for Combatting Disease said 103 cases of Ebola had been recorded in the eastern DRC as of August 22, 76 of which had been confirmed by laboratory tests.

Of the 103 cases, there were 61 deaths, 34 of which been confirmed by lab tests, while 27 others were considered "probable" cases of Ebola.

The outbreak began on August 1 in Mangina in North Kivu province, and cases have been reported in neighbouring Ituri province.

It is the 10th outbreak to strike the DRC since 1976, when Ebola was first identified and named after a river in the north of the country.

The Health Ministry added that "four additional experimental therapeutic molecules" had been approved by its ethics committee for treating infected patients.

Their laboratory names are ZMapp; Remdesivir; Favipiravir; and Regn3450 - 3471 - 3479.

The drugs -- which have not been licensed but undergone safety trials -- add to a prototype treatment called mAb114, whose use was announced on August 14.

The first therapeutic drug against the virus to be used in an active Ebola epidemic in the DRC, mAB114, has so far been given to 10 patients "who are responding positively," the ministry said.

Developed in the United States, the prototype drug is a so-called single monoclonal antibody -- a protein that binds on to a specific target of the virus and triggers the body's immune system to destroy the invader.

The experimental treatments are being used alongside an unlicensed vaccine called rVSV-ZEBOV, which was shown to be safe and effective in previous trials in an Ebola epidemic in West Africa.

Immunisation with rVSV-ZEBOV has been given to 2,179 front-line health workers, the ministry said.

The WHO has expressed concern that the violence in the province Kivu -- entailing militias who often fight for control of resources, including a notorious Ugandan rebel force called the Allied Democratic Forces (ADF) -- could hamper the fight against rolling back the disease.

The outbreak in eastern DRC was declared a week after WHO and the government hailed the end of a flareup in northwestern Equateur province, at the other end of the vast country, which killed 33 people.

The government has earmarked USD 43 million to fight the latest scare. Ebola is a highly contagious haemorrhagic fever caused by a virus which is believed to have a natural home in species of tropical bats.

It causes serious illness including vomiting, diarrhoea and in some cases internal and external bleeding. It is often fatal.

In the worst Ebola epidemic, the disease struck the West African states of Guinea, Liberia and Sierra Leone in 2013-15, killing more than 11,300 people.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 23 2018 | 6:10 PM IST

Next Story